Sun Exposure and Skin Cancer Risk
David Polsky, MD, PhD, Professor of Dermatology and Pathology; Alfred W. Kopf, MD, Professor of Dermatologic Oncology; Director, Pigmented Lesion Section; The Ronald O. Perelman Dept of Dermatology; New York […]
Entries by melindaroberts
Is there a Better Descriptive Name than Personalized Medicine?
Jerald P. Radich, MD, Director of the Molecular Oncology Lab at the Fred Hutchinson Cancer Research Center, and Professor of Medicine at the University of Washington School of Medicine, Seattle, […]
Seeing the Forest for the Trees: How Cancer Evolution Affects Treatment
Lisandra E. West, PhD, Senior Scientific Knowledge Engineer, CollabRx. Q: How might current thinking on tumor evolution/heterogeneity and sequential mutational profiling inform optimal therapy selection? A: I’d like to share some […]
Multiple Sequential Biopsies now Standard of Care in NSCLC
Gregory Otterson, MD, Professor of Internal Medicine; Interim Division Director of Medical Oncology; Co-Director, Thoracic Oncology Program; Program Director, Hematology & Medical Oncology Fellowship Program; The Ohio State University Wexner […]
Use CUREUS to Build Rapid Learning Communities
John R. Adler, Jr., MD, CEO & Editor-in-Chief Cureus.com; Dorothy & TK Chan Professor, Emeritus, Stanford University Q: CollabRx, and its “sister” not for profit organization “Cancer Commons”, are dedicated […]
Should All Potentially Lethal Tumors Be Sequenced?
Lisandra E. West, PhD, Senior Scientific Knowledge Engineer, CollabRx. Q: Is there enough benefit to justify sequencing all patients’ tumors? – Perspective from a scientific knowledge engineer. A: As a scientist […]
Use of Circulating Tumor Cells (CTCs) in Detection and Management of Lung Cancer
Ruth L. Katz, MD, Professor of Pathology, Director Image Analysis Lab; Chief research Cytopathology, University of Texas, MD Anderson Cancer center, Houston, Texas. Q: Liquid biopsy is “all the rage” […]
Can Precision Oncology Develop Despite Pharmaphobia?
Thomas P. Stossel, MD, American Cancer Society Professor of Medicine, Harvard Medical School; Senior Physician, Hematology Division, Brigham & Women’s Hospital, Boston, MA; Visiting Scholar, American Enterprise Institute; Secretary, Options […]
How do Phase 1 Clinical Trials for Cancer Drugs Work?
Razelle Kurzrock, MD, Chief, Division of Hematology and Oncology,UCSD School of Medicine; Senior Deputy Director, Clinical Science; Director, Center for Personalized Cancer Therapy; Director, Clinical Trials Office, UCSD Moores Cancer […]
NextGenU.org and the Prevention of Cancer
Erica Frank, MD, MPH, Professor and Canada Research Chair, University of British Columbia; Founder and President, NextGenU.org; Founding Member, CollabRx Editorial Advisory Board Q: What is Next Gen U and […]